SARS-CoV-2 continues to spread rapidly outside of mainland China. As of April 6 there are over 300000 cases and 10000 deaths in the US. Effective therapies for the novel Coronavirus are urgently needed and over 200 clinical trials are now underway across the globe. Recognizing the need for robust randomized control trials the World Health Organization WHO recently organized a multinational randomized trial-the SOLIDARITY trial-to study the effect of drugs that have been identified as promising based on in-vitro data and the early clinical experience with COVID-19: Remdesivir lopinavir and ritonavir; lopinavir and ritonavir + interferon; and chloroquine or hydroxychloroquine. Off-Label Therapies for COVID-19-Are We All In This Together?